Screener
Rhythm Pharmaceuticals, Inc. RYTM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total current liabilities | 103,198 | 105,942 |
| Long-term liabilities: | ||
| Deferred royalty obligation | 98,339 | 100,886 |
| Lease liability, non-current | 3,163 | 3,342 |
| Total liabilities | 204,700 | 210,170 |
| Commitments and contingencies (Note 14) | ||
| Series A convertible preferred stock, $0.001 par value: 150,000 shares authorized; 115,000 and 132,500 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference of $115,000 and $132,500 as of March 31, 2026, and December 31, 2025, respectively. | 114,710 | 130,957 |
| Stockholders’ equity: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s operating lease liabilities?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease liabilities of $3.16M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating lease liabilities decreased by 17.6% year-over-year, from $3.84M to $3.16M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 14.5% compound annual growth rate (CAGR), from $1.95M to $3.34M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude